HOME › DRUGS › INEBILIZUMAB
ACTIVE SUBSTANCE / INN

INEBILIZUMAB

Brand name(s): Uplizna
EMA LISTED
AUTHORISED
Neuromyelitis Optica
ACTIVE SUBSTANCE
Inebilizumab
REGULATORS
EMA
SPONSORS / MAH
Amgen Europe B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
UpliznaAmgen Europe B.V.Authorised25/04/2022Neuromyelitis Optica

FULL INTELLIGENCE ON INEBILIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →